-
1
-
-
0027378164
-
Cytogenetic deletion maps of hematologic neoplasm: Circumstantial evidence for tumor suppressor loci
-
Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasm: circumstantial evidence for tumor suppressor loci. Genes Chromos Cancer 1993; 8: 205-218.
-
(1993)
Genes Chromos Cancer
, vol.8
, pp. 205-218
-
-
Johansson, B.1
Mertens, F.2
Mitelman, F.3
-
2
-
-
0029014425
-
P53 activates expression of HIC-1 a new candidate tumor suppressor gene on 17p13.3
-
Makos Wales M, Biel MA, Diery W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB. p53 activates expression of HIC-1 a new candidate tumor suppressor gene on 17p13.3. Nature Med 1995; 1: 570-577.
-
(1995)
Nature Med
, vol.1
, pp. 570-577
-
-
Makos Wales, M.1
Biel, M.A.2
Diery, W.3
Nelkin, B.D.4
Issa, J.P.5
Cavenee, W.K.6
Kuerbitz, S.J.7
Baylin, S.B.8
-
3
-
-
0029877208
-
Identification of two candidate tumor suppressor genes on chromosome 17p13.3
-
Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ, Godwin AK. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 1996; 56: 1997-2002.
-
(1996)
Cancer Res
, vol.56
, pp. 1997-2002
-
-
Schultz, D.C.1
Vanderveer, L.2
Berman, D.B.3
Hamilton, T.C.4
Wong, A.J.5
Godwin, A.K.6
-
4
-
-
0028955808
-
TP53 mutation emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities
-
Kaneko H, Misawa S, Horiike S, Nakai H, Kashima K. TP53 mutation emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 1995; 85: 2189-2193.
-
(1995)
Blood
, vol.85
, pp. 2189-2193
-
-
Kaneko, H.1
Misawa, S.2
Horiike, S.3
Nakai, H.4
Kashima, K.5
-
5
-
-
0026561988
-
Mutations of P53 gene in B cell chronic lymphocytic leukemia: A report of 39 cases with cytogenetic analysis
-
Fenaux P, Preudhomme C, Lai JL, Quidquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lafebvre MH, Bauters F et al. Mutations of P53 gene in B cell chronic lymphocytic leukemia: a report of 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246-250.
-
(1992)
Leukemia
, vol.6
, pp. 246-250
-
-
Fenaux, P.1
Preudhomme, C.2
Lai, J.L.3
Quidquandon, I.4
Jonveaux, P.5
Vanrumbeke, M.6
Sartiaux, C.7
Morel, P.8
Loucheux-Lafebvre, M.H.9
Bauters, F.10
-
6
-
-
0028355613
-
Myelomonocytic crisis with t(15;17) and a p53 mutation in a person with chronic myelogenous leukemia
-
Nakagawa H, Fujii H, Nakai H, Inazawa J, Misawa S. Myelomonocytic crisis with t(15;17) and a p53 mutation in a person with chronic myelogenous leukemia. Am J Hematol 1994; 45: 335-340.
-
(1994)
Am J Hematol
, vol.45
, pp. 335-340
-
-
Nakagawa, H.1
Fujii, H.2
Nakai, H.3
Inazawa, J.4
Misawa, S.5
-
7
-
-
0027946095
-
Association of 17p loss with late stage or refractory disease in hematologic malignancy
-
Hawkins JM, Moorman AV, Hoffbrand AV, Martineau M, Wright FS, Mehta AB, Prentice HC, Seeker-Walker LM. Association of 17p loss with late stage or refractory disease in hematologic malignancy. Cancer Genet Cytogenet 1994; 77: 134-143.
-
(1994)
Cancer Genet Cytogenet
, vol.77
, pp. 134-143
-
-
Hawkins, J.M.1
Moorman, A.V.2
Hoffbrand, A.V.3
Martineau, M.4
Wright, F.S.5
Mehta, A.B.6
Prentice, H.C.7
Seeker-Walker, L.M.8
-
8
-
-
0026579237
-
TP53 tumor suppressor gene: A model for investigating human malignancies
-
Caron de Fromentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human malignancies. Genes Chromos Cancer 1992; 4: 1-15.
-
(1992)
Genes Chromos Cancer
, vol.4
, pp. 1-15
-
-
De Caron Fromentel, C.1
Soussi, T.2
-
10
-
-
0345575500
-
Loss of heterozygosity on chromosome 3, 13 and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma
-
Yokota J, Wada M, Shimosato Y, Terada M, Sugimura T. Loss of heterozygosity on chromosome 3, 13 and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma. Proc Natl Acad Sci USA 1987; 84: 9252-9256.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 9252-9256
-
-
Yokota, J.1
Wada, M.2
Shimosato, Y.3
Terada, M.4
Sugimura, T.5
-
11
-
-
0025250745
-
Allelotype of breast cancer: Cumulative allelic losses promote tumor progression in primary breast cancer
-
Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y. Allelotype of breast cancer: cumulative allelic losses promote tumor progression in primary breast cancer. Cancer Res 1990; 50: 7184-7189.
-
(1990)
Cancer Res
, vol.50
, pp. 7184-7189
-
-
Sato, T.1
Tanigami, A.2
Yamakawa, K.3
Akiyama, F.4
Kasumi, F.5
Sakamoto, G.6
Nakamura, Y.7
-
12
-
-
0025017058
-
Allelic losses of chromosome 9, 11 and 17 in human bladder cancer
-
Tsai YC, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK. Allelic losses of chromosome 9, 11 and 17 in human bladder cancer. Cancer Res 1990; 50: 44-47.
-
(1990)
Cancer Res
, vol.50
, pp. 44-47
-
-
Tsai, Y.C.1
Carlbom, E.2
Nordenskjold, M.3
Collins, V.P.4
Cavenee, W.K.5
-
13
-
-
0025941543
-
Allelotype of human ovarian cancer
-
Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. Allelotype of human ovarian cancer. Cancer Res 1991; 51: 5118-5122.
-
(1991)
Cancer Res
, vol.51
, pp. 5118-5122
-
-
Sato, T.1
Saito, H.2
Morita, R.3
Koi, S.4
Lee, J.H.5
Nakamura, Y.6
|